Monitoring and Predicting Health Status in Neurological Patients: The ALAMEDA Data Collection Protocol

被引:6
作者
Sorici, Alexandru [1 ]
Bajenaru, Lidia [1 ]
Mocanu, Irina Georgiana [1 ]
Florea, Adina Magda [1 ]
Tsakanikas, Panagiotis [2 ]
Ribigan, Athena Cristina [3 ,4 ]
Pedulla, Ludovico [5 ]
Bougea, Anastasia [6 ]
机构
[1] Natl Univ Sci & Technol Politehn Bucharest, AI MAS Lab, Bucharest 060042, Romania
[2] Natl Tech Univ Athens, Inst Commun & Comp Syst, Athens 10682, Greece
[3] Univ Emergency Hosp Bucharest, Dept Neurol, Bucharest 050098, Romania
[4] Univ Med & Pharm Carol Davila, Fac Med, Dept Neurol, Bucharest 050474, Romania
[5] Italian Multiple Sclerosis Fdn, Sci Res Area, I-16149 Genoa, Italy
[6] Natl & Kapodistrian Univ Athens, Eginit Hosp, Dept Neurol 1, Athens 11528, Greece
基金
欧盟地平线“2020”;
关键词
PD; MS; stroke; patient reported outcomes; wearables; quantitative motor analysis; sleep analysis; mood estimation; MULTIPLE-SCLEROSIS; PARKINSONS-DISEASE; WEARABLE DEVICES; SLEEP DISORDERS; STROKE; ACCURACY; BURDEN; PERFORMANCE; DISTURBANCE; DISABILITY;
D O I
10.3390/healthcare11192656
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
(1) Objective: We explore the predictive power of a novel stream of patient data, combining wearable devices and patient reported outcomes (PROs), using an AI-first approach to classify the health status of Parkinson's disease (PD), multiple sclerosis (MS) and stroke patients (collectively named PMSS). (2) Background: Recent studies acknowledge the burden of neurological disorders on patients and on the healthcare systems managing them. To address this, effort is invested in the digital transformation of health provisioning for PMSS patients. (3) Methods: We introduce the data collection journey within the ALAMEDA project, which continuously collects PRO data for a year through mobile applications and supplements them with data from minimally intrusive wearable devices (accelerometer bracelet, IMU sensor belt, ground force measuring insoles, and sleep mattress) worn for 1-2 weeks at each milestone. We present the data collection schedule and its feasibility, the mapping of medical predictor variables to wearable device capabilities and mobile application functionality. (4) Results: A novel combination of wearable devices and smartphone applications required for the desired analysis of motor, sleep, emotional and quality-of-life outcomes is introduced. AI-first analysis methods are presented that aim to uncover the prediction capability of diverse longitudinal and cross-sectional setups (in terms of standard medical test targets). Mobile application development and usage schedule facilitates the retention of patient engagement and compliance with the study protocol.
引用
收藏
页数:46
相关论文
共 89 条
[1]   Assessment of Multiple Sclerosis Disability Progression Using a Wearable Biosensor: A Pilot Study [J].
Abbadessa, Gianmarco ;
Lavorgna, Luigi ;
Miele, Giuseppina ;
Mignone, Alfredo ;
Signoriello, Elisabetta ;
Lus, Giacomo ;
Clerico, Marinella ;
Sparaco, Maddalena ;
Bonavita, Simona .
JOURNAL OF CLINICAL MEDICINE, 2021, 10 (06) :1-8
[2]   Neuroplastic Changes Following Brain Ischemia and their Contribution to Stroke Recovery: Novel Approaches in Neurorehabilitation [J].
Alia, Claudia ;
Spalletti, Cristina ;
Lai, Stefano ;
Panarese, Alessandro ;
Lamola, Giuseppe ;
Bertolucci, Federica ;
Vallone, Fabio ;
Di Garbo, Angelo ;
Chisari, Carmelo ;
Micera, Silvestro ;
Caleo, Matteo .
FRONTIERS IN CELLULAR NEUROSCIENCE, 2017, 11
[3]   Sleep disturbance in mental health problems and neurodegenerative disease [J].
Anderson, Kirstie N. ;
Bradley, Andrew J. .
NATURE AND SCIENCE OF SLEEP, 2013, 5 :61-75
[4]   Wearable sensors can reliably quantify gait alterations associated with disability in people with progressive multiple sclerosis in a clinical setting [J].
Angelini, Lorenza ;
Hodgkinson, William ;
Smith, Craig ;
Dodd, Jessie Moorman ;
Sharrack, Basil ;
Mazza, Claudia ;
Paling, David .
JOURNAL OF NEUROLOGY, 2020, 267 (10) :2897-2909
[5]  
[Anonymous], 2022, Research Studies Using the GENEACtiv Bracelet
[6]   Acceptability to patients, carers and clinicians of an mHealth platform for the management of Parkinson's disease (PD_Manager): study protocol for a pilot randomised controlled trial [J].
Antonini, Angelo ;
Gentile, Giovanni ;
Giglio, Manuela ;
Marcante, Andrea ;
Gage, Heather ;
Touray, Morro M. L. ;
Fotiadis, Dimitrios I. ;
Gatsios, Dimitris ;
Konitsiotis, Spyridon ;
Timotijevic, Lada ;
Egan, Bernadette ;
Hodgkins, Charo ;
Biundo, Roberta ;
Pellicano, Clelia .
TRIALS, 2018, 19
[7]   What is the risk of permanent disability from a multiple sclerosis relapse? [J].
Bejaoui, Khemissa ;
Rolak, Loren A. .
NEUROLOGY, 2010, 74 (11) :900-902
[8]   Sleep and neurodegenerative diseases [J].
Bhatt, MH ;
Podder, N ;
Chokroverty, S .
SEMINARS IN NEUROLOGY, 2005, 25 (01) :39-51
[9]   Multi-ethnic study of atherosclerosis: Objectives and design [J].
Bild, DE ;
Bluemke, DA ;
Burke, GL ;
Detrano, R ;
Roux, AVD ;
Folsom, AR ;
Greenland, P ;
Jacobs, DR ;
Kronmal, R ;
Liu, K ;
Nelson, JC ;
O'Leary, D ;
Saad, MF ;
Shea, S ;
Szklo, M ;
Tracy, RP .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 156 (09) :871-881
[10]   A narrative review of running wearable measurement system accuracy and reliability: can we make running shoe prescription objective? [J].
Blazey, Paul ;
Michie, Tom, V ;
Napier, Christopher .
FOOTWEAR SCIENCE, 2021, 13 (02) :117-131